PTO- 1478 |
Approved for use through 06/30/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90791385 |
Filing Date: 06/23/2021 |
Input Field |
Entered |
TEAS Plus | YES |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\907\913\90791385\xml1 \ FTK0002.JPG |
*SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | AR Adaptive Research |
*COLOR MARK | YES |
*COLOR(S) CLAIMED (If applicable) |
The color(s) red and white and grey or black and white is/are claimed as a feature of the mark. |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of a circle with the letters AR in the circle and next to the circle the name ADAPTIVE RESEARCH with a missing bar in the A appearing in the circle and in the name spelled out and the R in the circle missing vertical bar and with a piece if the D missing in Adaptive as well as the name Research being a smaller font size than Adaptive. |
PIXEL COUNT ACCEPTABLE | NO |
PIXEL COUNT | 952 x 1232 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Adaptive Research Inc. |
*MAILING ADDRESS | 548 Market Street, Suite 26181 |
*CITY | San Francisco |
*STATE (Required for U.S. applicants) |
California |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
26181 |
PHONE | 301-717-3129 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
*TYPE | CORPORATION |
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
*INTERNATIONAL CLASS | 035 |
*IDENTIFICATION | Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval |
*FILING BASIS | SECTION 1(b) |
*INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | Conducting clinical trials for others; Conducting clinical trials for others in the field of scientific and medical research; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Providing information in the field of clinical research via a website; Providing medical and scientific research information in the field of clinical trials |
*FILING BASIS | SECTION 1(b) |
ADDITIONAL STATEMENTS SECTION | |
*TRANSLATION (if applicable) |
|
*TRANSLITERATION (if applicable) |
|
*CLAIMED PRIOR REGISTRATION (if applicable) |
|
*CONSENT (NAME/LIKENESS) (if applicable) |
|
*CONCURRENT USE CLAIM (if applicable) |
|
ATTORNEY INFORMATION | |
NAME | Thomas J. Knapp |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
STREET | 7116 Darby Road |
CITY | Bethesda |
STATE | Maryland |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 20817 |
PHONE | 301-717-3129 |
EMAIL ADDRESS | thomas.j.knapp@gmail.com |
CORRESPONDENCE INFORMATION | |
NAME | Thomas J. Knapp |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | thomas.j.knapp@gmail.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | t.j.knapp@adaptiveresearch.org |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Plus |
NUMBER OF CLASSES | 2 |
APPLICATION FOR REGISTRATION PER CLASS | 250 |
*TOTAL FEES DUE | 500 |
*TOTAL FEES PAID | 500 |
SIGNATURE INFORMATION | |
* SIGNATURE | /Thomas J. Knapp/ |
* SIGNATORY'S NAME | Thomas J. Knapp |
* SIGNATORY'S POSITION | Attorney |
SIGNATORY'S PHONE NUMBER | 301-717-3129 |
* DATE SIGNED | 06/23/2021 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 06/30/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90791385 |
Filing Date: 06/23/2021 |
The applicant's current Correspondence Information: |
Thomas J. Knapp |
PRIMARY EMAIL FOR CORRESPONDENCE: thomas.j.knapp@gmail.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): t.j.knapp@adaptiveresearch.org Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|